BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31241286)

  • 1. Potential impact of strong tobacco-control policies in 11 newly independent states.
    Levy DT; Levy J; Mauer-Stender K
    Cent Eur J Public Health; 2019 Jun; 27(2):115-126. PubMed ID: 31241286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential health impact of strong tobacco control policies in 11 South Eastern WHO European Region countries.
    Levy DT; Wijnhoven TMA; Levy J; Yuan Z; Mauer-Stender K
    Eur J Public Health; 2018 Aug; 28(4):693-701. PubMed ID: 29554253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Russia SimSmoke: the long-term effects of tobacco control policies on smoking prevalence and smoking-attributable deaths in Russia.
    Maslennikova GY; Oganov RG; Boytsov SA; Ross H; Huang AT; Near A; Kotov A; Berezhnova I; Levy DT
    Tob Control; 2014 Nov; 23(6):484-90. PubMed ID: 23853252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of public policies in reducing smoking: the Minnesota SimSmoke tobacco policy model.
    Levy DT; Boyle RG; Abrams DB
    Am J Prev Med; 2012 Nov; 43(5 Suppl 3):S179-86. PubMed ID: 23079215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seven years of progress in tobacco control: an evaluation of the effect of nations meeting the highest level MPOWER measures between 2007 and 2014.
    Levy DT; Yuan Z; Luo Y; Mays D
    Tob Control; 2018 Jan; 27(1):50-57. PubMed ID: 27956650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential effects of tobacco control in China: projections from the China SimSmoke simulation model.
    Levy D; Rodríguez-Buño RL; Hu TW; Moran AE
    BMJ; 2014 Feb; 348():g1134. PubMed ID: 24550245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global smoking-related deaths averted due to MPOWER policies implemented at the highest level between 2007 and 2020.
    Lyle G; Hendrie D
    Global Health; 2024 May; 20(1):40. PubMed ID: 38715053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mexico SimSmoke: how changes in tobacco control policies would impact smoking prevalence and smoking attributable deaths in Mexico.
    Fleischer NL; Thrasher JF; Reynales-Shigematsu LM; Cummings KM; Meza R; Zhang Y; Levy DT
    Glob Public Health; 2017 Jul; 12(7):830-845. PubMed ID: 26837721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of nations meeting the MPOWER targets between 2014 and 2016: an update.
    Levy DT; Li Y; Yuan Z
    Tob Control; 2020 Mar; 29(2):231-233. PubMed ID: 31053650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the Abridged SimSmoke model to four Eastern Mediterranean countries.
    Levy DT; Fouad H; Levy J; Dragomir AD; El Awa F
    Tob Control; 2016 Jul; 25(4):413-21. PubMed ID: 26080365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of tobacco control policies on smoking prevalence and smoking-attributable deaths. Findings from the Netherlands SimSmoke Tobacco Control Policy Simulation Model.
    Nagelhout GE; Levy DT; Blackman K; Currie L; Clancy L; Willemsen MC
    Addiction; 2012 Feb; 107(2):407-16. PubMed ID: 21906197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Country-specific costs of implementing the WHO FCTC tobacco control policies and potential financing sources.
    Shang C; Yadav A; Stoklosa M; Kontsevaya A; Lewis FB; Pana A; Reyes I
    PLoS One; 2018; 13(10):e0204903. PubMed ID: 30281668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tobacco control policy on cardiovascular morbidity and mortality in Russia.
    Gambaryan M; Reeves A; Deev A; Popovich M; Drapkina O; Snell A; Stuckler D; Mauer-Stender K; Mikkelsen B; Boytsov S
    Eur J Public Health; 2018 Oct; 28(suppl_2):14-16. PubMed ID: 30371836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of public policies in reducing smoking prevalence: results from the Michigan SimSmoke tobacco policy simulation model.
    Levy DT; Huang AT; Havumaki JS; Meza R
    Cancer Causes Control; 2016 May; 27(5):615-25. PubMed ID: 26983616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of tobacco control policies on smoking prevalence and smoking-attributable deaths in Ireland using the IrelandSS simulation model.
    Currie LM; Blackman K; Clancy L; Levy DT
    Tob Control; 2013 May; 22(e1):e25-32. PubMed ID: 22634570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global Implementation of Tobacco Demand Reduction Measures Specified in Framework Convention on Tobacco Control.
    Hiilamo H; Glantz S
    Nicotine Tob Res; 2022 Mar; 24(4):503-510. PubMed ID: 34661672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tobacco control policies on smoking prevalence and tobacco-attributable deaths in Mexico: the SimSmoke model.
    Reynales-Shigematsu LM; Fleischer NL; Thrasher JF; Zhang Y; Meza R; Cummings KM; Levy DT
    Rev Panam Salud Publica; 2015 Oct; 38(4):316-25. PubMed ID: 26758223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco control policy in the UK: blueprint for the rest of Europe?
    Levy DT; Currie L; Clancy L
    Eur J Public Health; 2013 Apr; 23(2):201-6. PubMed ID: 22826505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries: an association study.
    Gravely S; Giovino GA; Craig L; Commar A; D'Espaignet ET; Schotte K; Fong GT
    Lancet Public Health; 2017 Apr; 2(4):e166-e174. PubMed ID: 29253448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobacco control in the Russian Federation--a policy analysis.
    Lunze K; Migliorini L
    BMC Public Health; 2013 Jan; 13():64. PubMed ID: 23339756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.